Opportunity Information: Apply for W81XWH 16 NFRP IIRA
Apply for W81XWH 16 NFRP IIRA
- The DOD-AMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Neurofibromatosis Investigator-Initiated Research Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on May 09, 2016 and posted on May 09, 2016.
- Applicants must submit their applications by Aug 01, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Neurofibromatosis Investigator-Initiated Research Award (IIRA) is a funding opportunity under the Department of Defense Neurofibromatosis Research Program (NFRP) designed to support investigator-driven projects that are both highly rigorous and positioned to make a meaningful impact on neurofibromatosis (NF) research and/or patient care. The emphasis is on high-impact science that can advance understanding of NF, improve clinical management, or meaningfully shift the field forward. The program is intentionally broad in the types of research it will consider, allowing proposals across virtually any phase of research, as long as the work does not involve clinical trials. In other words, applicants can propose basic, translational, or other non-trial clinical research approaches, but they cannot propose a clinical trial as the primary activity.
A key feature of this award is that it is “investigator-initiated,” meaning the central idea comes from the applicant rather than being narrowly defined by a pre-set topic list. The program explicitly acknowledges that strong research ideas can originate from multiple pathways: a laboratory discovery that suggests a new mechanism or target, population-based or epidemiological observations, a clinician’s firsthand experience treating patients, or even well-supported anecdotal patterns that merit systematic testing. Regardless of where the idea originates, applications must be grounded in evidence. The opportunity requires preliminary and/or published data that are directly relevant to NF and to the proposed project, signaling that proposals are expected to be more than speculative and should have a concrete foundation supporting feasibility and relevance.
The announcement also places heavy weight on rigor and reproducibility, particularly for preclinical work. Applicants are expected to design studies using widely accepted best practices that improve transparency and strengthen the likelihood that findings will translate. The opportunity points applicants to the standards discussed in Landis, S.C., et al., “A call for transparent reporting to optimize the predictive value of preclinical research” (Nature, 2012), and it highlights several core principles that should be incorporated where applicable: randomization, blinding, sample-size estimation, and clear plans for data handling. Although that Nature paper is framed around preclinical research, the program notes that these fundamentals reflect established scientific best practices and should be applied broadly. The overarching message is that strong ideas are not enough; the design, execution, and reporting plan must be robust and defensible.
For projects that use animal models, the requirements become more specific. Applicants proposing animal work must include an Animal Research Plan (referred to as “Attachment 8”) within the application package, explaining exactly how the project will address the rigorous design and reporting standards. In addition, applicants are directed to consult the ARRIVE guidelines (Animal Research Reporting In Vivo Experiments) so that critical elements of animal study planning and eventual reporting are properly considered from the start. This emphasis reflects an intent to improve the quality, interpretability, and reproducibility of animal studies, and to increase the translational potential of results.
Administratively, the opportunity is listed as Funding Opportunity Number W81XWH-16-NFRP-IIRA and is managed by DOD-AMRAA. It is categorized as discretionary funding and allows for funding instruments such as grants and cooperative agreements under the Science and Technology and other Research and Development activity category (CFDA 12.420). Eligibility is described as “unrestricted,” meaning it is broadly open to various entity types, subject to any additional eligibility language included in the full announcement. The posting date is May 9, 2016, with an application closing date of August 1, 2016 (as listed for both original and current closing). The opportunity anticipates making a small number of awards (expected awards: 2), indicating a competitive process with selective funding decisions. The award ceiling is not specified in the provided text, so applicants would need to consult the full solicitation for budget limits and other submission details.
In practical terms, this award is best suited for researchers who already have NF-relevant data and a well-developed, high-impact research question, and who can demonstrate a rigorous study design with strong attention to reproducibility. The program’s combination of broad scientific scope (excluding clinical trials) and strict expectations for methodological transparency signals that it aims to fund projects that are both innovative and dependable, with results that can credibly inform future NF research directions and, ultimately, patient care.
Frequently Asked Questions (FAQs): DoD Neurofibromatosis Investigator-Initiated Research Award (IIRA)
What is the DoD Neurofibromatosis Investigator-Initiated Research Award (IIRA)?
The IIRA is a funding opportunity within the Department of Defense (DoD) Neurofibromatosis Research Program (NFRP) intended to support investigator-driven research projects that are scientifically rigorous and likely to make a meaningful impact on neurofibromatosis (NF) research and/or patient care.
What is the main goal or emphasis of this award?
The central emphasis is on high-impact science that can advance understanding of NF, improve clinical management, or otherwise meaningfully shift the field forward. Strong ideas are expected, but the program also places major weight on rigorous design, execution, and reporting plans.
What does “investigator-initiated” mean in this context?
“Investigator-initiated” means the project concept originates from the applicant rather than from a narrow, pre-defined topic list. The program is intentionally broad and welcomes compelling ideas from many sources, provided the application is grounded in evidence.
What kinds of research ideas are considered appropriate for an investigator-initiated proposal?
The opportunity notes that strong NF research ideas can come from multiple pathways, including laboratory discoveries that suggest new mechanisms or targets, population-based or epidemiological observations, a clinician’s firsthand experience treating patients, or well-supported anecdotal patterns that merit systematic testing. Regardless of origin, the idea must be supported by NF-relevant evidence.
What phases or types of research are allowed under this funding opportunity?
The program is broad in scope and indicates it will consider proposals across virtually any phase of research, as long as the work does not involve clinical trials. This includes basic research, translational research, and other non-trial clinical research approaches.
Are clinical trials allowed under the IIRA?
No. The opportunity allows proposals across many phases of research, but it explicitly excludes clinical trials as the primary activity. Applicants can pursue non-trial clinical research approaches, but they cannot propose a clinical trial as the main component of the project.
Does the application need preliminary data?
Yes. The opportunity requires preliminary and/or published data that are directly relevant to neurofibromatosis and to the proposed project. This requirement signals that applications are expected to be grounded in evidence and not purely speculative.
How important are rigor and reproducibility in this program?
Rigor and reproducibility are emphasized heavily, especially for preclinical work. Applicants are expected to incorporate widely accepted best practices that improve transparency and strengthen the likelihood that findings will translate.
What best-practice design elements does the opportunity highlight for rigorous research?
The announcement highlights core principles that should be incorporated where applicable, including randomization, blinding, sample-size estimation, and clear plans for data handling. The overall expectation is a robust and defensible study design and reporting plan.
Does the opportunity reference any specific rigor or reporting standards?
Yes. It points applicants to the standards discussed in Landis, S.C., et al., “A call for transparent reporting to optimize the predictive value of preclinical research” (Nature, 2012) and underscores that the fundamentals described there reflect established scientific best practices that should be applied broadly.
What additional requirements apply if my project uses animal models?
If animal models are used, applicants must include an Animal Research Plan (referred to as “Attachment 8”) within the application package. This plan should describe how the project will address rigorous design and reporting standards for animal work.
Are there specific guidelines applicants should follow for animal studies?
Yes. Applicants are directed to consult the ARRIVE guidelines (Animal Research Reporting In Vivo Experiments) to ensure critical elements of animal study planning and reporting are considered from the start.
What is the Funding Opportunity Number for this award?
The Funding Opportunity Number listed is W81XWH-16-NFRP-IIRA.
Who manages this funding opportunity?
The opportunity is managed by DOD-AMRAA.
What type of funding mechanism does this opportunity use?
The opportunity allows for funding instruments such as grants and cooperative agreements.
How is the funding categorized?
It is categorized as discretionary funding and falls under the Science and Technology and other Research and Development activity category (CFDA 12.420).
Who is eligible to apply?
Eligibility is described as “unrestricted,” meaning it is broadly open to various entity types, subject to any additional eligibility language included in the full announcement.
When was this opportunity posted?
The posting date listed is May 9, 2016.
What is the application deadline?
The application closing date listed is August 1, 2016 (shown as both the original and current closing date in the provided information).
How many awards are expected to be made?
The opportunity anticipates a small number of awards, with expected awards listed as 2. This suggests a competitive and selective funding process.
What is the maximum award amount (award ceiling)?
The award ceiling is not specified in the provided text. Applicants would need to consult the full solicitation for budget limits and related submission details.
What kind of applicant is this award best suited for?
This award is best suited for researchers who already have NF-relevant preliminary and/or published data, a well-developed and high-impact research question, and a study design that demonstrates strong attention to rigor, transparency, and reproducibility.
What is the overall message the program sends about proposal quality?
The program’s message is that strong ideas alone are not enough. Proposed work must be supported by NF-relevant evidence and must include a robust, defensible plan for study design, execution, and reporting, especially where preclinical or animal research is involved.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: BLM-Arizona, AZ Strip District Cultural Resources Support
Previous opportunity: FY16 Tuberous Sclerosis Complex Synergistic Idea Development Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 16 NFRP IIRA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 16 NFRP IIRA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Neurofibromatosis Clinical Trial Award Apply for W81XWH 16 NFRP CTA Funding Number: W81XWH 16 NFRP CTA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Tuberous Sclerosis Complex Postdoctoral Development Award Apply for W81XWH 16 TSCRP PDA Funding Number: W81XWH 16 TSCRP PDA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| NSF/DOE Partnership in Basic Plasma Science and Engineering Apply for 16 564 Funding Number: 16 564 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: $250,000 |
| Regional Alliances and Multistakeholder Partnerships to Stimulate (RAMPS) Cybersecurity Education and Workforce Development Apply for 2016 NIST NICE 01 Funding Number: 2016 NIST NICE 01 Agency: DOC-NIST Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Enhance the Ability of Emergency Medical Services (EMS) to transport patients with highly infectious diseases (HID) Apply for EP IDS 16 003 Funding Number: EP IDS 16 003 Agency: HHS-OS-ASPR Category: Science and Technology and other Research and Development Funding Amount: $350,000 |
| TRADES Apply for DARPA BAA 16 39 Funding Number: DARPA BAA 16 39 Agency: DOD-DARPA-DSO Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Small Business Innovation Research Program (SBIR) Phase II 93.433 HHS/ACL/NIDILRR Apply for HHS 2016 ACL NIDILRR BISB 0182 Funding Number: HHS 2016 ACL NIDILRR BISB 0182 Agency: HHS-ACL Category: Science and Technology and other Research and Development Funding Amount: $575,000 |
| AAAS Science and Technology Policy Fellowships Apply for P16AS00159 Funding Number: P16AS00159 Agency: DOI-NPS Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Early Stage Innovations (ESI) Apply for NNH16ZOA001N 16ESI B2 Funding Number: NNH16ZOA001N 16ESI B2 Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: $500,000 |
| DoD Gulf War Illness Clinical Partnership Award Apply for W81XWH 16 GWIRP CPA Funding Number: W81XWH 16 GWIRP CPA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness Treatment Evaluation Award Apply for W81XWH 16 GWIRP TEA Funding Number: W81XWH 16 GWIRP TEA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness Epidemiology Research Award Apply for W81XWH 16 GWIRP GWIERA Funding Number: W81XWH 16 GWIRP GWIERA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness New Investigator Award Apply for W81XWH 16 GWIRP NIA Funding Number: W81XWH 16 GWIRP NIA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Investigator-Initiated Apply for W81XWH 16 SCIRP IIRA Funding Number: W81XWH 16 SCIRP IIRA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Translational Award Apply for W81XWH 16 SCIRP TRA Funding Number: W81XWH 16 SCIRP TRA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness Investigator-Initiated Focused Research Award Apply for W81XWH 16 GWIRP IIRFA Funding Number: W81XWH 16 GWIRP IIRFA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Psychological Health/Traumatic Brain Injury Cognitive Resilience and Readiness Research Award Apply for W81XWH 16 PHTBIRP CR3A Funding Number: W81XWH 16 PHTBIRP CR3A Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Computer and Information Science and Engineering (CISE) Research Initiation Initiative Apply for 16 565 Funding Number: 16 565 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: $175,000 |
| ROSES 2016: Modeling, Analysis, and Prediction Apply for NNH16ZDA001N MAP Funding Number: NNH16ZDA001N MAP Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Qualitative Award Apply for W81XWH 16 SCIRP QRA Funding Number: W81XWH 16 SCIRP QRA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 16 NFRP IIRA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
